Choice of antiviral allocation scheme for pandemic influenza depends on strain transmissibility, delivery delay and stockpile size
From MaRDI portal
(Redirected from Publication:281119)
Recommendations
- Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic
- Antiviral treatment for pandemic influenza: assessing potential repercussions using a seasonally forced SIR model
- Selfish drug allocation for containing an international influenza pandemic at the onset
- Optimal control for pandemic influenza: the role of limited antiviral treatment and isolation
- Deterministic model for the role of antivirals in controlling the spread of the H1N1 influenza pandemic
Cites work
- scientific article; zbMATH DE number 1598672 (Why is no real title available?)
- scientific article; zbMATH DE number 3987697 (Why is no real title available?)
- scientific article; zbMATH DE number 939788 (Why is no real title available?)
- Branching Process Approximation of Epidemic Models
- Deterministic epidemic models with explicit household structure
- Epidemics with two levels of mixing
- Modeling infectious diseases in humans and animals
- Optimal vaccination policies for stochastic epidemics among a population of households
- Reproduction numbers for epidemic models with households and other social structures. I: Definition and calculation of \(R_{0}\)
- Solutions of ordinary differential equations as limits of pure jump markov processes
- The effect of clumped population structure on the variability of spreading dynamics
Cited in
(3)
This page was built for publication: Choice of antiviral allocation scheme for pandemic influenza depends on strain transmissibility, delivery delay and stockpile size
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q281119)